Rosamaria Ruggieri

Title: Rosamaria Ruggieri: Innovator in Cancer Treatment

Introduction

Rosamaria Ruggieri is a prominent inventor based in Roslyn Estates, NY (US). She has made significant contributions to the field of cancer treatment, particularly in the area of solid tumors. Her innovative work focuses on developing methods and compounds that target malignant tumors, showcasing her dedication to advancing medical research.

Latest Patents

Rosamaria Ruggieri holds a patent for the treatment of solid tumors by inhibiting MRK/ZAK. This patent describes methods and compounds for treating malignant, neoplastic solid tumors such as glioblastoma and medulloblastoma. The invention includes pharmaceutical compositions containing a MRK/ZAK inhibitor compound and a pharmaceutically acceptable carrier. Additionally, it outlines a method for sensitizing tumor cells to radiation therapy by administering an effective amount of the MRK/ZAK inhibitor compound. She has 1 patent to her name.

Career Highlights

Ruggieri is affiliated with The Feinstein Institute for Medical Research, where she continues her groundbreaking work in cancer research. Her career is marked by a commitment to improving treatment options for patients suffering from aggressive forms of cancer.

Collaborations

Throughout her career, Rosamaria has collaborated with esteemed colleagues, including Yousef Al-Abed and Marc Symons. These partnerships have further enriched her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Rosamaria Ruggieri's innovative contributions to cancer treatment exemplify her dedication to medical research and patient care. Her work in inhibiting MRK/ZAK activity represents a significant step forward in the fight against solid tumors.